Have you noticed obvious cognitive decline in vaccinated family, friends, and co-workers?

BY PAUL JUNOR

Attention has focused on the side effects of the COVID-19 vaccination since the government push in 2019. The many side effects of this vaccination protocol have been well documented.

According to the government of Canada’s website, some of the common side effects include: redness, soreness, and swelling at the injection site as well as possible rare allergic reactions, which may occur such as: difficulty breathing, swelling of the face, tongue or throat, and hives (bumps on the skin that are often very itchy).

There is a list of serious side effects of the Johnson/Johnson COVID-19 vaccine that can manifest within three weeks after injection and may require emergency care, which according to the Mayo Clinic’s website include: shortness of breath, persistent stomach pain, severe or persistent headaches or blurred vision, chest pain. leg swelling, easy bruising or tiny spots on the skin beyond the injection site.

One of the serious side effects that have provoked widespread response is cognitive defects and memory impairments. It was first reported in the journal, Brain Behaviour Immunity, & Health on July 22^nd, 2022, and co-authored by Bipin Chaurasia, Vishal Chavda, Bingwei Lu, and Kanwaljeet Gard.

The article was published online on April 23^rd, 2022 and reported that a 65-year-old man developed cognitive effects and memory impairments after receiving the first dose of Oxford AstraZeneca vaccine (Covishied). It notes “The onset of acute cognitive effects and memory impairments could be another complications to COVID-19 vaccines that physicians and neurologists need to be warmed to. The patient was admitted to the hospital after the emergence of sudden memory loss for one day.” The article revealed that, “He was unable to describe both short and long-term memory previously acquired. On examination, his speech was of a non-fluent type characterized by isolated words. He was completely unaware of his presence in the hospital.”

The authors in the article noted that “Our 65-year-old patient was healthy before the immunization, but he developed mild to moderate cognitive impairment afterward. The effects of vaccination after the first or second dosage are still poorly known, which is why there is so little literature for cognitive and memory deficits after vaccination.”

There is a reference ascribed to an article in the J. Clin. Med 10 (15), 3441 by Ali Awan et. al .n 2021

The four co-authors in the journal article proposed a hypothesis  that may explain the occurrence of cognitive impairment and memory deficit after COVID-19 vaccination. It has to do with the T and B cells, which are important in the immune response of the body through their involvement in normal neuronal activities. They hypothesized that the Adenovirus vaccine vector, which is found in the Covishield vaccine, attaches to the mutated virus vector of the COVID–19 virus and disrupts cytokine function. This affects the inflammatory reaction in the immune cells connected with the mutated virus vector, resulting in the decrease in B and T memory cells and thus cognitive decline that is immunologically mediated.

Attention must be directed to the importance of monitoring the safety of vaccines in order to increase their safety and the overall trust of the public. The co-authors stressed the importance of having a functional adverse event monitoring system to ensure that all cases of adverse events related to COVID-19 vaccination are reported in the public domain.